Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 18Carcinoma, Non-Small-Cell Lung 6Glioma 5Brain Neoplasms 5Head and Neck Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Astrocytoma 3Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pain 2Lung Neoplasms 2Gliosarcoma 2Central Nervous System Neoplasms 2Bone Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomatitis 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Nervous System Diseases 1Neoplasms by Site 1

Interventions

Pemetrexed 5ponatinib 4pembrolizumab 4Carboplatin 4Cisplatin 3130-nm albumin-bound paclitaxel 3tetulomab tetraxetan lu-177 2pralsetinib 2osimertinib 2napabucasin 2fludarabine 2ficlatuzumab 2entinostat 2durvalumab 2atezolizumab 2Rituximab 2Paclitaxel 2Lutetium 2Irinotecan 2Immunotherapy 2Imatinib Mesylate 2Gemcitabine 2Doxorubicin 2Dexamethasone 2Cyclophosphamide 2Bortezomib 2Bevacizumab 2vorasidenib 1siltuximab 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms by Histologic Type × Radiation × Clear all
NCT03150862 2025-02-04

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

BeiGene

Phase 1/2 Completed
116 enrolled 31 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nervous System Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡